S 7753 New York Senate · 2023 Regular Session

Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

Summary
Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.
Bill status in committee 1 of 4 stages cleared
Introduction
Nov 2023
Committee Review
Floor Vote
Governor
Introduced Nov 15, 2023 Last action Jan 3, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 3, 2024
Committee
REFERRED TO HEALTH
upper
Nov 15, 2023
Committee
REFERRED TO RULES
upper
1 primary · 1 co-sponsor

Sponsors